85-1405-51 Von Willebrand Factor, Factor VIII Free, Human (vWF, Factor VIII Related Antigen) 100ug V2651

※お見積書はカートで印刷できます

冷凍 保管・搬送時に冷凍が必要な商品です。

特徴

  • Multimeric Structure of von Willebrand Factor: Each vWF monomer (Mr = 260kD) contains a Factor VIII binding site near the NH2-terminal end of the molecule. The monomers are joined end-to-end (NH2 to NH2 and COOH to COOH) by disulfide bonds to form large multimers. The mature multimers can bind one Factor VIII molecule per monomeric subunit.  Von Willebrand Factor (vWF) is a multimeric plasma glycoprotein that is required for normal hemostatic platelet plug formation (1-8). The mature plasma protein is composed of apparently identical subunits (Mr = 260kD) which are held together by disulfide bonds. The circulating vWF molecule ranges in size from dimers (Mr = 520kD) to extremely large multimers (Mr > 10,000,000). During normal hemostasis, the larger multimers of vWF are responsible for facilitating platelet plug formation by forming a bridge between platelet glycoprotein IB and exposed collagen in the subendothelium (9-14). Either a lack of vWF protein or the presence of abnormalities which result in decreased polymerization may cause a loss of biological activity which is characteristic of von Willebrand's Disease.
  • In addition to its role in platelet plug formation, vWF is also responsible for the binding and transport of Factor VIII (Antihemophilic Aactor) in plasma (15). It appears that this latter event is responsible for both the stability and effective delivery of functional Factor VIII. Studies indicate that Factor VIII binds to the NH2-terminal portion of the mature vWF subunit with a stoichiometry of one Factor VIII molecule per vWF monomer (16,17).
  • The single chain vWF monomer contains a large number of cysteine residues at both the NH2-terminal and COOH-terminal ends, which are involved in the multimer formation. Carbohydrate analyses indicate that nearly 15% of the mass of vWF is contributed by carbohydrate (18). It appears that the carbohydrate serves to protect vWF from proteolysis, but is not necessary for functional activity or multimer formation.
  • Localization:Plasma and subendothelium
  • Mode of Action:Facilitates platelet plug formation by forming a bridge between platelet glycoprotein IB and exposed collagen in the subendothelium. Also binds and transports Factor VIII.
  • Molecular Weight:Monomer: 260kDMultimers: 1-20 x 1000kD (multimers)
  • Structure:Multimeric protein composed of identical 250kD molecular weight subunits.
  • Storage and Stability:Store at -70°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
  • Note:Immediately after removal from dry ice (-80°C). Thaw in 37°C water bath for several minutes to prevent a precipitation of vWF. Do not agitate or vortex.
  • Related Product:V2650: Von Willebrand Factor, Human

仕様

  • Size:100ug
  • Source Antigen:Human plasma
  • Grade:Highly Purified
  • Purity:≥95% by SDS-PAGE
  • Form:Supplied as a liquid in 25mM sodium citrate, 100mM glycine, 100mM sodium chloride, pH 6.8.
  • Molecular Weight Non Ab:260
  • EU Commodity Code:38220090
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
85-1405-51
型番
V2651
入り数
1個
標準価格
267,000円(税抜)
WEB価格
-円
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:点

お買い物を続ける カートを見る